Buctolan, Baby Boy .

HRN: 24-45-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2024
AMPICILLIN 250MG (VIAL)
01/25/2024
02/01/2024
IV
100mg
Q12
PSNB
Waiting Final Action 
01/25/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/25/2024
02/01/2024
IV
24mg
Q24
PSNB
Waiting Final Action 
01/26/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
01/26/2024
02/01/2024
IV
24mg As LD Then 12mg
Q24
Prematurity
Waiting Final Action 
01/27/2024
CEFOTAXIME 500MG (VIAL)
01/27/2024
02/02/2024
IV
100mg
BID
Potentially Septic Newborn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: